Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-5925 | wolf-screen-ratio-mammosphere-adherent | 0.802 | 2.42e-06 | 4.82e-03 | 8.69e-03 | 8 | 5 |
int-snw-23192 | wolf-screen-ratio-mammosphere-adherent | 0.993 | 7.89e-18 | 6.58e-04 | 1.50e-02 | 13 | 13 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
PPCS | 79717 | 31 | -0.569 | 0.802 | 2 | - | Yes |
RBX1 | 9978 | 115 | 1.185 | 0.934 | 148 | Yes | - |
PPIE | 10450 | 31 | 0.567 | 0.802 | 41 | - | - |
TUBA1C | 84790 | 5 | 0.966 | 0.993 | 91 | Yes | - |
OGDH | 4967 | 72 | 0.847 | 0.802 | 126 | Yes | - |
TFRC | 7037 | 31 | 0.730 | 0.802 | 17 | - | - |
RPSA | 3921 | 120 | 1.327 | 1.151 | 152 | Yes | - |
RPL11 | 6135 | 21 | 0.718 | 1.017 | 200 | Yes | - |
PGD | 5226 | 89 | 1.201 | 1.106 | 152 | Yes | - |
RPA2 | 6118 | 96 | 1.250 | 1.151 | 76 | Yes | - |
RB1 | 5925 | 31 | -0.102 | 0.802 | 351 | - | - |
RSL24D1 | 51187 | 38 | 1.300 | 1.020 | 59 | Yes | - |
EEF2 | 1938 | 64 | 0.890 | 1.043 | 301 | Yes | - |
CLTC | 1213 | 56 | 0.884 | 1.138 | 247 | Yes | - |
RPL14 | 9045 | 49 | 1.250 | 1.113 | 166 | Yes | - |
ACTB | 60 | 134 | 1.153 | 1.151 | 610 | Yes | - |
ATG4B | 23192 | 2 | -0.110 | 0.993 | 159 | - | Yes |
CFL1 | 1072 | 18 | 0.674 | 1.020 | 203 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
EEF2 | 1938 | PGD | 5226 | pp | -- | int.I2D: BioGrid_Yeast |
RB1 | 5925 | PPCS | 79717 | pd | > | reg.pazar.txt: no annot |
ACTB | 60 | RPL11 | 6135 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ATG4B | 23192 | TUBA1C | 84790 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RB1 | 5925 | RPA2 | 6118 | pd | > | reg.pazar.txt: no annot |
ACTB | 60 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
RPL11 | 6135 | ATG4B | 23192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
CLTC | 1213 | ATG4B | 23192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
PGD | 5226 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
RBX1 | 9978 | PPIE | 10450 | pd | <> | reg.ITFP.txt: no annot |
ACTB | 60 | EEF2 | 1938 | pp | -- | int.I2D: YeastLow, IntAct_Yeast |
ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
ACTB | 60 | ATG4B | 23192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
OGDH | 4967 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | CFL1 | 1072 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, MINT_Yeast, MIPS, BioGrid, BIND_Yeast, HPRD, IntAct, IntAct_Yeast, MINT, VidalHuman_core, YeastLow, Yu_GoldStd; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
OGDH | 4967 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
CFL1 | 1072 | ATG4B | 23192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
ACTB | 60 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
RPL11 | 6135 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
CFL1 | 1072 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
CFL1 | 1072 | OGDH | 4967 | pp | -- | int.I2D: YeastLow |
RB1 | 5925 | TFRC | 7037 | pd | > | reg.ITFP.txt: no annot |
CFL1 | 1072 | RSL24D1 | 51187 | pp | -- | int.I2D: YeastLow |
EEF2 | 1938 | ATG4B | 23192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RB1 | 5925 | PPIE | 10450 | pd | > | reg.pazar.txt: no annot |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0006414 | translational elongation | 2.84e-06 | 4.64e-02 | 5.285 | 4 | 11 | 93 |
GO:0044267 | cellular protein metabolic process | 1.03e-05 | 1.68e-01 | 3.458 | 6 | 24 | 495 |
GO:0031982 | vesicle | 1.22e-05 | 1.98e-01 | 4.758 | 4 | 10 | 134 |
GO:0016032 | viral process | 1.69e-05 | 2.75e-01 | 3.333 | 6 | 55 | 540 |
GO:0042273 | ribosomal large subunit biogenesis | 8.90e-05 | 1.00e+00 | 7.124 | 2 | 4 | 13 |
GO:0044822 | poly(A) RNA binding | 8.97e-05 | 1.00e+00 | 2.558 | 7 | 50 | 1078 |
GO:0019083 | viral transcription | 9.11e-05 | 1.00e+00 | 5.070 | 3 | 8 | 81 |
GO:0070062 | extracellular vesicular exosome | 9.87e-05 | 1.00e+00 | 1.850 | 10 | 98 | 2516 |
GO:0006412 | translation | 1.09e-04 | 1.00e+00 | 3.948 | 4 | 15 | 235 |
GO:0006415 | translational termination | 1.13e-04 | 1.00e+00 | 4.967 | 3 | 8 | 87 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.91e-04 | 1.00e+00 | 4.709 | 3 | 8 | 104 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.51e-04 | 1.00e+00 | 4.577 | 3 | 10 | 114 |
GO:0019058 | viral life cycle | 2.57e-04 | 1.00e+00 | 4.564 | 3 | 10 | 115 |
GO:0016020 | membrane | 2.75e-04 | 1.00e+00 | 2.055 | 8 | 80 | 1746 |
GO:0006413 | translational initiation | 3.78e-04 | 1.00e+00 | 4.376 | 3 | 12 | 131 |
GO:0003735 | structural constituent of ribosome | 4.68e-04 | 1.00e+00 | 4.270 | 3 | 8 | 141 |
GO:0006457 | protein folding | 5.50e-04 | 1.00e+00 | 4.190 | 3 | 8 | 149 |
GO:0033572 | transferrin transport | 5.59e-04 | 1.00e+00 | 5.825 | 2 | 6 | 32 |
GO:0005515 | protein binding | 6.03e-04 | 1.00e+00 | 1.051 | 14 | 172 | 6127 |
GO:0005829 | cytosol | 7.16e-04 | 1.00e+00 | 1.671 | 9 | 125 | 2562 |
GO:0051084 | 'de novo' posttranslational protein folding | 7.48e-04 | 1.00e+00 | 5.615 | 2 | 4 | 37 |
GO:0031625 | ubiquitin protein ligase binding | 9.53e-04 | 1.00e+00 | 3.918 | 3 | 13 | 180 |
GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 1 |
GO:0004632 | phosphopantothenate--cysteine ligase activity | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 1 |
GO:0022625 | cytosolic large ribosomal subunit | 1.31e-03 | 1.00e+00 | 5.210 | 2 | 5 | 49 |
GO:0003725 | double-stranded RNA binding | 1.59e-03 | 1.00e+00 | 5.070 | 2 | 6 | 54 |
GO:0016071 | mRNA metabolic process | 1.76e-03 | 1.00e+00 | 3.609 | 3 | 34 | 223 |
GO:0045252 | oxoglutarate dehydrogenase complex | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 2 | 2 |
GO:0097286 | iron ion import | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 2 |
GO:0061034 | olfactory bulb mitral cell layer development | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 2 |
GO:0004998 | transferrin receptor activity | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 2 |
GO:0031134 | sister chromatid biorientation | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 2 | 2 |
GO:0016070 | RNA metabolic process | 2.36e-03 | 1.00e+00 | 3.461 | 3 | 34 | 247 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 3.20e-03 | 1.00e+00 | 4.558 | 2 | 5 | 77 |
GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 3 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 3 |
GO:0071439 | clathrin complex | 3.31e-03 | 1.00e+00 | 8.240 | 1 | 1 | 3 |
GO:0006898 | receptor-mediated endocytosis | 3.97e-03 | 1.00e+00 | 4.398 | 2 | 2 | 86 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0071922 | regulation of cohesin localization to chromatin | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0032051 | clathrin light chain binding | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0001842 | neural fold formation | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0006104 | succinyl-CoA metabolic process | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 4 |
GO:0016605 | PML body | 4.53e-03 | 1.00e+00 | 4.301 | 2 | 5 | 92 |
GO:0042470 | melanosome | 4.53e-03 | 1.00e+00 | 4.301 | 2 | 10 | 92 |
GO:0005200 | structural constituent of cytoskeleton | 4.63e-03 | 1.00e+00 | 4.285 | 2 | 7 | 93 |
GO:0019901 | protein kinase binding | 4.90e-03 | 1.00e+00 | 3.088 | 3 | 21 | 320 |
GO:0006364 | rRNA processing | 4.93e-03 | 1.00e+00 | 4.240 | 2 | 5 | 96 |
GO:0010467 | gene expression | 5.41e-03 | 1.00e+00 | 2.439 | 4 | 58 | 669 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 2 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 2 | 5 |
GO:0000730 | DNA recombinase assembly | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 3 | 5 |
GO:0006734 | NADH metabolic process | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 5 |
GO:0030976 | thiamine pyrophosphate binding | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 5 |
GO:0003723 | RNA binding | 6.53e-03 | 1.00e+00 | 2.938 | 3 | 19 | 355 |
GO:0043353 | enucleate erythrocyte differentiation | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 6 |
GO:0009108 | coenzyme biosynthetic process | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 6 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 6 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 6 |
GO:0021860 | pyramidal neuron development | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 6 |
GO:0030118 | clathrin coat | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 6 |
GO:0021695 | cerebellar cortex development | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 4 | 6 |
GO:0030529 | ribonucleoprotein complex | 6.88e-03 | 1.00e+00 | 3.992 | 2 | 8 | 114 |
GO:0005819 | spindle | 6.88e-03 | 1.00e+00 | 3.992 | 2 | 7 | 114 |
GO:0072562 | blood microparticle | 7.11e-03 | 1.00e+00 | 3.967 | 2 | 4 | 116 |
GO:0005925 | focal adhesion | 7.32e-03 | 1.00e+00 | 2.878 | 3 | 18 | 370 |
GO:0000028 | ribosomal small subunit assembly | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 2 | 7 |
GO:0030132 | clathrin coat of coated pit | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 7 |
GO:0030836 | positive regulation of actin filament depolymerization | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 2 | 7 |
GO:0016018 | cyclosporin A binding | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 7 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 2 | 8 |
GO:0070688 | MLL5-L complex | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 8 |
GO:0006554 | lysine catabolic process | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 2 | 8 |
GO:0045116 | protein neddylation | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 2 | 8 |
GO:0030042 | actin filament depolymerization | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 2 | 8 |
GO:0015937 | coenzyme A biosynthetic process | 9.88e-03 | 1.00e+00 | 6.655 | 1 | 1 | 9 |
GO:0008494 | translation activator activity | 9.88e-03 | 1.00e+00 | 6.655 | 1 | 1 | 9 |
GO:0097284 | hepatocyte apoptotic process | 9.88e-03 | 1.00e+00 | 6.655 | 1 | 2 | 9 |
GO:0000075 | cell cycle checkpoint | 9.88e-03 | 1.00e+00 | 6.655 | 1 | 2 | 9 |
GO:0015939 | pantothenate metabolic process | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 10 |
GO:0021756 | striatum development | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 10 |
GO:0061024 | membrane organization | 1.11e-02 | 1.00e+00 | 3.635 | 2 | 5 | 146 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.17e-02 | 1.00e+00 | 3.596 | 2 | 33 | 150 |
GO:0006098 | pentose-phosphate shunt | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 3 | 11 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 3 | 11 |
GO:0042551 | neuron maturation | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 11 |
GO:0061001 | regulation of dendritic spine morphogenesis | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 11 |
GO:0005198 | structural molecule activity | 1.30e-02 | 1.00e+00 | 3.512 | 2 | 4 | 159 |
GO:0051146 | striated muscle cell differentiation | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 1 | 12 |
GO:0021794 | thalamus development | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 1 | 12 |
GO:0005662 | DNA replication factor A complex | 1.42e-02 | 1.00e+00 | 6.124 | 1 | 3 | 13 |
GO:0045780 | positive regulation of bone resorption | 1.42e-02 | 1.00e+00 | 6.124 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 4 | 14 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 1 | 14 |
GO:0045445 | myoblast differentiation | 1.64e-02 | 1.00e+00 | 5.918 | 1 | 2 | 15 |
GO:0016514 | SWI/SNF complex | 1.64e-02 | 1.00e+00 | 5.918 | 1 | 3 | 15 |
GO:0050998 | nitric-oxide synthase binding | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 1 | 16 |
GO:0006103 | 2-oxoglutarate metabolic process | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 1 | 16 |
GO:0003746 | translation elongation factor activity | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 3 | 17 |
GO:0045070 | positive regulation of viral genome replication | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 17 |
GO:0031258 | lamellipodium membrane | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 2 | 17 |
GO:0022604 | regulation of cell morphogenesis | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 1 | 17 |
GO:0035861 | site of double-strand break | 1.97e-02 | 1.00e+00 | 5.655 | 1 | 1 | 18 |
GO:0003924 | GTPase activity | 2.07e-02 | 1.00e+00 | 3.159 | 2 | 9 | 203 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 19 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 2.18e-02 | 1.00e+00 | 5.503 | 1 | 2 | 20 |
GO:0006298 | mismatch repair | 2.18e-02 | 1.00e+00 | 5.503 | 1 | 6 | 20 |
GO:0030010 | establishment of cell polarity | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 2 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 5 | 21 |
GO:0000281 | mitotic cytokinesis | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 2 | 21 |
GO:0006184 | GTP catabolic process | 2.40e-02 | 1.00e+00 | 3.043 | 2 | 9 | 220 |
GO:0030316 | osteoclast differentiation | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 2 | 22 |
GO:0010508 | positive regulation of autophagy | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 22 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 5 | 22 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 3 | 22 |
GO:0032201 | telomere maintenance via semi-conservative replication | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 7 | 22 |
GO:0030863 | cortical cytoskeleton | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 4 | 22 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 2.51e-02 | 1.00e+00 | 5.301 | 1 | 2 | 23 |
GO:0043236 | laminin binding | 2.51e-02 | 1.00e+00 | 5.301 | 1 | 1 | 23 |
GO:0043200 | response to amino acid | 2.51e-02 | 1.00e+00 | 5.301 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 2.51e-02 | 1.00e+00 | 5.301 | 1 | 1 | 23 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.51e-02 | 1.00e+00 | 5.301 | 1 | 4 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 2.51e-02 | 1.00e+00 | 5.301 | 1 | 1 | 23 |
GO:0030864 | cortical actin cytoskeleton | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 1 | 25 |
GO:0005844 | polysome | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 4 | 25 |
GO:0000045 | autophagic vacuole assembly | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 26 |
GO:0000722 | telomere maintenance via recombination | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 7 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 26 |
GO:0005654 | nucleoplasm | 2.89e-02 | 1.00e+00 | 1.728 | 4 | 83 | 1095 |
GO:0019843 | rRNA binding | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 3 | 27 |
GO:0048565 | digestive tract development | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 1 | 27 |
GO:0051258 | protein polymerization | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 2 | 27 |
GO:0007017 | microtubule-based process | 3.04e-02 | 1.00e+00 | 5.017 | 1 | 3 | 28 |
GO:0043022 | ribosome binding | 3.04e-02 | 1.00e+00 | 5.017 | 1 | 3 | 28 |
GO:0031492 | nucleosomal DNA binding | 3.04e-02 | 1.00e+00 | 5.017 | 1 | 4 | 28 |
GO:0019894 | kinesin binding | 3.04e-02 | 1.00e+00 | 5.017 | 1 | 1 | 28 |
GO:0006099 | tricarboxylic acid cycle | 3.15e-02 | 1.00e+00 | 4.967 | 1 | 3 | 29 |
GO:0019005 | SCF ubiquitin ligase complex | 3.15e-02 | 1.00e+00 | 4.967 | 1 | 1 | 29 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 3.15e-02 | 1.00e+00 | 4.967 | 1 | 1 | 29 |
GO:0034504 | protein localization to nucleus | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 2 | 30 |
GO:0001755 | neural crest cell migration | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 2 | 30 |
GO:0042254 | ribosome biogenesis | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 30 |
GO:0007346 | regulation of mitotic cell cycle | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 3 | 30 |
GO:0006281 | DNA repair | 3.36e-02 | 1.00e+00 | 2.780 | 2 | 22 | 264 |
GO:0031623 | receptor internalization | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 1 | 31 |
GO:0006271 | DNA strand elongation involved in DNA replication | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 9 | 31 |
GO:0007093 | mitotic cell cycle checkpoint | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 2 | 31 |
GO:0050661 | NADP binding | 3.47e-02 | 1.00e+00 | 4.825 | 1 | 1 | 32 |
GO:0051219 | phosphoprotein binding | 3.47e-02 | 1.00e+00 | 4.825 | 1 | 3 | 32 |
GO:0031072 | heat shock protein binding | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 2 | 33 |
GO:0000413 | protein peptidyl-prolyl isomerization | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 34 |
GO:0004175 | endopeptidase activity | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 2 | 34 |
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 34 |
GO:0032588 | trans-Golgi network membrane | 3.90e-02 | 1.00e+00 | 4.655 | 1 | 1 | 36 |
GO:0034332 | adherens junction organization | 3.90e-02 | 1.00e+00 | 4.655 | 1 | 1 | 36 |
GO:0051402 | neuron apoptotic process | 3.90e-02 | 1.00e+00 | 4.655 | 1 | 2 | 36 |
GO:0001895 | retina homeostasis | 3.90e-02 | 1.00e+00 | 4.655 | 1 | 1 | 36 |
GO:0006605 | protein targeting | 3.90e-02 | 1.00e+00 | 4.655 | 1 | 2 | 36 |
GO:0008234 | cysteine-type peptidase activity | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 2 | 37 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 4 | 37 |
GO:0070527 | platelet aggregation | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 2 | 38 |
GO:0050681 | androgen receptor binding | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 4 | 38 |
GO:0021766 | hippocampus development | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 4 | 39 |
GO:0006284 | base-excision repair | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 7 | 39 |
GO:0006096 | glycolytic process | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 4 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 3 | 39 |
GO:0043234 | protein complex | 4.24e-02 | 1.00e+00 | 2.596 | 2 | 17 | 300 |
GO:0000781 | chromosome, telomeric region | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 2 | 40 |
GO:0005881 | cytoplasmic microtubule | 4.43e-02 | 1.00e+00 | 4.467 | 1 | 2 | 41 |
GO:0030521 | androgen receptor signaling pathway | 4.43e-02 | 1.00e+00 | 4.467 | 1 | 2 | 41 |
GO:0035914 | skeletal muscle cell differentiation | 4.53e-02 | 1.00e+00 | 4.432 | 1 | 1 | 42 |
GO:0006892 | post-Golgi vesicle-mediated transport | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 2 | 44 |
GO:0021762 | substantia nigra development | 4.96e-02 | 1.00e+00 | 4.301 | 1 | 1 | 46 |
GO:0030136 | clathrin-coated vesicle | 4.96e-02 | 1.00e+00 | 4.301 | 1 | 1 | 46 |
GO:0001047 | core promoter binding | 4.96e-02 | 1.00e+00 | 4.301 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 4.96e-02 | 1.00e+00 | 4.301 | 1 | 8 | 46 |
GO:0045727 | positive regulation of translation | 4.96e-02 | 1.00e+00 | 4.301 | 1 | 4 | 46 |
GO:0007411 | axon guidance | 4.96e-02 | 1.00e+00 | 2.471 | 2 | 9 | 327 |
GO:0005525 | GTP binding | 4.98e-02 | 1.00e+00 | 2.467 | 2 | 11 | 328 |
GO:0007266 | Rho protein signal transduction | 5.17e-02 | 1.00e+00 | 4.240 | 1 | 2 | 48 |
GO:0006091 | generation of precursor metabolites and energy | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 3 | 51 |
GO:0005905 | coated pit | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 2 | 51 |
GO:0003684 | damaged DNA binding | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 11 | 51 |
GO:0045732 | positive regulation of protein catabolic process | 5.48e-02 | 1.00e+00 | 4.152 | 1 | 4 | 51 |
GO:0019900 | kinase binding | 5.79e-02 | 1.00e+00 | 4.070 | 1 | 1 | 54 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 5.79e-02 | 1.00e+00 | 4.070 | 1 | 5 | 54 |
GO:0050680 | negative regulation of epithelial cell proliferation | 5.79e-02 | 1.00e+00 | 4.070 | 1 | 1 | 54 |
GO:0006879 | cellular iron ion homeostasis | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 5 | 57 |
GO:0000724 | double-strand break repair via homologous recombination | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 6 | 57 |
GO:0002244 | hematopoietic progenitor cell differentiation | 6.21e-02 | 1.00e+00 | 3.967 | 1 | 1 | 58 |
GO:0051087 | chaperone binding | 6.31e-02 | 1.00e+00 | 3.942 | 1 | 6 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 6.31e-02 | 1.00e+00 | 3.942 | 1 | 4 | 59 |
GO:0045216 | cell-cell junction organization | 6.31e-02 | 1.00e+00 | 3.942 | 1 | 2 | 59 |
GO:0000723 | telomere maintenance | 6.31e-02 | 1.00e+00 | 3.942 | 1 | 8 | 59 |
GO:0031966 | mitochondrial membrane | 6.31e-02 | 1.00e+00 | 3.942 | 1 | 1 | 59 |
GO:0006302 | double-strand break repair | 6.62e-02 | 1.00e+00 | 3.870 | 1 | 8 | 62 |
GO:0019903 | protein phosphatase binding | 6.73e-02 | 1.00e+00 | 3.847 | 1 | 4 | 63 |
GO:0006469 | negative regulation of protein kinase activity | 6.93e-02 | 1.00e+00 | 3.802 | 1 | 2 | 65 |
GO:0000278 | mitotic cell cycle | 7.02e-02 | 1.00e+00 | 2.188 | 2 | 52 | 398 |
GO:0001558 | regulation of cell growth | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 4 | 66 |
GO:0006338 | chromatin remodeling | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 4 | 68 |
GO:0006289 | nucleotide-excision repair | 7.35e-02 | 1.00e+00 | 3.716 | 1 | 12 | 69 |
GO:0003697 | single-stranded DNA binding | 7.35e-02 | 1.00e+00 | 3.716 | 1 | 9 | 69 |
GO:0034329 | cell junction assembly | 7.55e-02 | 1.00e+00 | 3.675 | 1 | 1 | 71 |
GO:0032587 | ruffle membrane | 7.65e-02 | 1.00e+00 | 3.655 | 1 | 4 | 72 |
GO:0055037 | recycling endosome | 7.76e-02 | 1.00e+00 | 3.635 | 1 | 2 | 73 |
GO:0000785 | chromatin | 7.76e-02 | 1.00e+00 | 3.635 | 1 | 5 | 73 |
GO:0006767 | water-soluble vitamin metabolic process | 7.96e-02 | 1.00e+00 | 3.596 | 1 | 3 | 75 |
GO:0007265 | Ras protein signal transduction | 7.96e-02 | 1.00e+00 | 3.596 | 1 | 3 | 75 |
GO:0031175 | neuron projection development | 7.96e-02 | 1.00e+00 | 3.596 | 1 | 1 | 75 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 8.06e-02 | 1.00e+00 | 3.577 | 1 | 3 | 76 |
GO:0006914 | autophagy | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 1 | 77 |
GO:0006766 | vitamin metabolic process | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 3 | 78 |
GO:0071013 | catalytic step 2 spliceosome | 8.37e-02 | 1.00e+00 | 3.521 | 1 | 7 | 79 |
GO:0051301 | cell division | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 6 | 81 |
GO:0002576 | platelet degranulation | 8.67e-02 | 1.00e+00 | 3.467 | 1 | 4 | 82 |
GO:0047485 | protein N-terminus binding | 9.08e-02 | 1.00e+00 | 3.398 | 1 | 4 | 86 |
GO:0007596 | blood coagulation | 9.15e-02 | 1.00e+00 | 1.967 | 2 | 14 | 464 |
GO:0005615 | extracellular space | 9.64e-02 | 1.00e+00 | 1.429 | 3 | 17 | 1010 |
GO:0016363 | nuclear matrix | 9.68e-02 | 1.00e+00 | 3.301 | 1 | 11 | 92 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 9.68e-02 | 1.00e+00 | 3.301 | 1 | 4 | 92 |
GO:0006928 | cellular component movement | 9.68e-02 | 1.00e+00 | 3.301 | 1 | 7 | 92 |
GO:0001649 | osteoblast differentiation | 9.98e-02 | 1.00e+00 | 3.255 | 1 | 6 | 95 |
GO:0042802 | identical protein binding | 1.01e-01 | 1.00e+00 | 1.885 | 2 | 18 | 491 |
GO:0007010 | cytoskeleton organization | 1.01e-01 | 1.00e+00 | 3.240 | 1 | 2 | 96 |
GO:0071456 | cellular response to hypoxia | 1.03e-01 | 1.00e+00 | 3.210 | 1 | 4 | 98 |
GO:0014069 | postsynaptic density | 1.11e-01 | 1.00e+00 | 3.097 | 1 | 1 | 106 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 1.12e-01 | 1.00e+00 | 3.083 | 1 | 3 | 107 |
GO:0042127 | regulation of cell proliferation | 1.16e-01 | 1.00e+00 | 3.030 | 1 | 4 | 111 |
GO:0044237 | cellular metabolic process | 1.23e-01 | 1.00e+00 | 2.942 | 1 | 3 | 118 |
GO:0006325 | chromatin organization | 1.27e-01 | 1.00e+00 | 2.882 | 1 | 4 | 123 |
GO:0007219 | Notch signaling pathway | 1.29e-01 | 1.00e+00 | 2.859 | 1 | 4 | 125 |
GO:0006260 | DNA replication | 1.29e-01 | 1.00e+00 | 2.859 | 1 | 12 | 125 |
GO:0007050 | cell cycle arrest | 1.30e-01 | 1.00e+00 | 2.847 | 1 | 7 | 126 |
GO:0005634 | nucleus | 1.32e-01 | 1.00e+00 | 0.587 | 8 | 131 | 4828 |
GO:0030036 | actin cytoskeleton organization | 1.33e-01 | 1.00e+00 | 2.813 | 1 | 5 | 129 |
GO:0009615 | response to virus | 1.36e-01 | 1.00e+00 | 2.780 | 1 | 6 | 132 |
GO:0000790 | nuclear chromatin | 1.37e-01 | 1.00e+00 | 2.769 | 1 | 7 | 133 |
GO:0005911 | cell-cell junction | 1.46e-01 | 1.00e+00 | 2.675 | 1 | 3 | 142 |
GO:0045087 | innate immune response | 1.46e-01 | 1.00e+00 | 1.558 | 2 | 20 | 616 |
GO:0010628 | positive regulation of gene expression | 1.52e-01 | 1.00e+00 | 2.605 | 1 | 4 | 149 |
GO:0000398 | mRNA splicing, via spliceosome | 1.67e-01 | 1.00e+00 | 2.458 | 1 | 12 | 165 |
GO:0044281 | small molecule metabolic process | 1.67e-01 | 1.00e+00 | 1.071 | 3 | 57 | 1295 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 5 | 168 |
GO:0030424 | axon | 1.74e-01 | 1.00e+00 | 2.398 | 1 | 3 | 172 |
GO:0006886 | intracellular protein transport | 1.75e-01 | 1.00e+00 | 2.390 | 1 | 4 | 173 |
GO:0005768 | endosome | 1.76e-01 | 1.00e+00 | 2.382 | 1 | 5 | 174 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.78e-01 | 1.00e+00 | 2.357 | 1 | 25 | 177 |
GO:0009897 | external side of plasma membrane | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 4 | 183 |
GO:0032403 | protein complex binding | 1.86e-01 | 1.00e+00 | 2.293 | 1 | 7 | 185 |
GO:0030168 | platelet activation | 2.04e-01 | 1.00e+00 | 2.145 | 1 | 9 | 205 |
GO:0007067 | mitotic nuclear division | 2.26e-01 | 1.00e+00 | 1.973 | 1 | 13 | 231 |
GO:0005759 | mitochondrial matrix | 2.28e-01 | 1.00e+00 | 1.960 | 1 | 12 | 233 |
GO:0003713 | transcription coactivator activity | 2.33e-01 | 1.00e+00 | 1.924 | 1 | 10 | 239 |
GO:0008134 | transcription factor binding | 2.39e-01 | 1.00e+00 | 1.882 | 1 | 8 | 246 |
GO:0004842 | ubiquitin-protein transferase activity | 2.48e-01 | 1.00e+00 | 1.825 | 1 | 4 | 256 |
GO:0005874 | microtubule | 2.49e-01 | 1.00e+00 | 1.813 | 1 | 6 | 258 |
GO:0000166 | nucleotide binding | 2.61e-01 | 1.00e+00 | 1.737 | 1 | 6 | 272 |
GO:0005975 | carbohydrate metabolic process | 2.63e-01 | 1.00e+00 | 1.726 | 1 | 5 | 274 |
GO:0003779 | actin binding | 2.64e-01 | 1.00e+00 | 1.721 | 1 | 7 | 275 |
GO:0019899 | enzyme binding | 2.74e-01 | 1.00e+00 | 1.655 | 1 | 11 | 288 |
GO:0005730 | nucleolus | 2.82e-01 | 1.00e+00 | 0.692 | 3 | 70 | 1684 |
GO:0016567 | protein ubiquitination | 2.83e-01 | 1.00e+00 | 1.601 | 1 | 5 | 299 |
GO:0005856 | cytoskeleton | 2.93e-01 | 1.00e+00 | 1.544 | 1 | 8 | 311 |
GO:0043231 | intracellular membrane-bounded organelle | 3.09e-01 | 1.00e+00 | 1.449 | 1 | 8 | 332 |
GO:0015031 | protein transport | 3.29e-01 | 1.00e+00 | 1.345 | 1 | 4 | 357 |
GO:0007155 | cell adhesion | 3.49e-01 | 1.00e+00 | 1.240 | 1 | 8 | 384 |
GO:0006508 | proteolysis | 3.68e-01 | 1.00e+00 | 1.145 | 1 | 9 | 410 |
GO:0009986 | cell surface | 3.76e-01 | 1.00e+00 | 1.103 | 1 | 9 | 422 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.78e-01 | 1.00e+00 | 1.097 | 1 | 14 | 424 |
GO:0043066 | negative regulation of apoptotic process | 3.84e-01 | 1.00e+00 | 1.066 | 1 | 30 | 433 |
GO:0006468 | protein phosphorylation | 4.07e-01 | 1.00e+00 | 0.957 | 1 | 10 | 467 |
GO:0055114 | oxidation-reduction process | 4.17e-01 | 1.00e+00 | 0.915 | 1 | 11 | 481 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.20e-01 | 1.00e+00 | 0.897 | 1 | 17 | 487 |
GO:0055085 | transmembrane transport | 4.38e-01 | 1.00e+00 | 0.819 | 1 | 8 | 514 |
GO:0048471 | perinuclear region of cytoplasm | 4.44e-01 | 1.00e+00 | 0.794 | 1 | 12 | 523 |
GO:0005737 | cytoplasm | 4.56e-01 | 1.00e+00 | 0.189 | 5 | 98 | 3976 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.70e-01 | 1.00e+00 | 0.278 | 1 | 11 | 748 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.01e-01 | 1.00e+00 | 0.161 | 1 | 19 | 811 |
GO:0005886 | plasma membrane | 6.28e-01 | 1.00e+00 | -0.059 | 3 | 38 | 2834 |
GO:0005887 | integral component of plasma membrane | 6.65e-01 | 1.00e+00 | -0.084 | 1 | 7 | 961 |
GO:0005739 | mitochondrion | 6.97e-01 | 1.00e+00 | -0.206 | 1 | 24 | 1046 |
GO:0005576 | extracellular region | 6.98e-01 | 1.00e+00 | -0.210 | 1 | 9 | 1049 |
GO:0008270 | zinc ion binding | 7.04e-01 | 1.00e+00 | -0.235 | 1 | 12 | 1067 |
GO:0006355 | regulation of transcription, DNA-templated | 7.17e-01 | 1.00e+00 | -0.284 | 1 | 17 | 1104 |
GO:0003677 | DNA binding | 7.89e-01 | 1.00e+00 | -0.575 | 1 | 26 | 1351 |
GO:0005524 | ATP binding | 7.90e-01 | 1.00e+00 | -0.578 | 1 | 46 | 1354 |
GO:0046872 | metal ion binding | 8.16e-01 | 1.00e+00 | -0.692 | 1 | 24 | 1465 |
GO:0006351 | transcription, DNA-templated | 8.41e-01 | 1.00e+00 | -0.806 | 1 | 25 | 1585 |